These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 39247824)

  • 1. Multiomics analyses decipher intricate changes in the cellular and metabolic landscape of steatotic livers upon dietary restriction and sleeve gastrectomy.
    Chen S; Zeng Q; Cai X; Xue J; Yin G; Song P; Tang L; Klein C; Tacke F; Guillot A; Liu H
    Int J Biol Sci; 2024; 20(11):4438-4457. PubMed ID: 39247824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid metabolic reprogramming mediated by circulating Nrg4 alleviates metabolic dysfunction-associated steatotic liver disease during the early recovery phase after sleeve gastrectomy.
    Yang C; Zhu D; Liu C; Wang W; He Y; Wang B; Li M
    BMC Med; 2024 Apr; 22(1):164. PubMed ID: 38632600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endoplasmic reticulum stress inhibitor may substitute for sleeve gastrectomy to alleviate metabolic dysfunction-associated steatotic liver disease.
    Pei E; Wang H; Li Z; Xie X; Cai L; Lin M
    Clin Res Hepatol Gastroenterol; 2023 Dec; 47(10):102229. PubMed ID: 37865225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear miR-204-3p mitigates metabolic dysfunction-associated steatotic liver disease in mice.
    Zou Z; Liu X; Yu J; Ban T; Zhang Z; Wang P; Huang R; Zheng F; Chang Y; Peng W; Tang Y; Feng X; Zhao Z; Lv X; Huang S; Guo J; Tuo Y; Zhou Z; Liang S
    J Hepatol; 2024 Jun; 80(6):834-845. PubMed ID: 38331323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex-based differences in natural killer T cell-mediated protection against diet-induced steatohepatitis in Balb/c mice.
    Cuño-Gómiz C; de Gregorio E; Tutusaus A; Rider P; Andrés-Sánchez N; Colell A; Morales A; Marí M
    Biol Sex Differ; 2023 Nov; 14(1):85. PubMed ID: 37964320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patchouli alcohol alleviates metabolic dysfunction-associated steatohepatitis via inhibiting mitochondria-associated endoplasmic reticulum membrane disruption-induced hepatic steatosis and inflammation in rats.
    Xie X; Liao Y; Lin Z; Luo H; Wei G; Huang N; Li Y; Chen J; Su Z; Yu X; Chen L; Liu Y
    Int Immunopharmacol; 2024 Sep; 138():112634. PubMed ID: 38971107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphofunctional Changes After Sleeve Gastrectomy and Very Low Calorie Diet in an Animal Model of Non-Alcoholic Fatty Liver Disease.
    Talavera-Urquijo E; Rodríguez-Navarro S; Beisani M; Salcedo-Allende MT; Chakkur A; Arús-Avilés M; Cremades M; Augustin S; Martell M; Balibrea JM
    Obes Surg; 2018 Jan; 28(1):142-151. PubMed ID: 28710554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sleeve gastrectomy attenuates high fat diet-induced non-alcoholic fatty liver disease.
    Pei E; Liu Y; Jiang W; Lin S; Huang L; Lin M; Cai L
    Lipids Health Dis; 2018 Oct; 17(1):243. PubMed ID: 30355361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic Ablation of STE20-Type Kinase MST4 Does Not Alleviate Diet-Induced MASLD Susceptibility in Mice.
    Caputo M; Andersson E; Xia Y; Hou W; Cansby E; Erikson M; Lind DE; Hallberg B; Amrutkar M; Mahlapuu M
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38397122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elongation factor 1A1 inhibition elicits changes in lipid droplet size, the bulk transcriptome, and cell type-associated gene expression in MASLD mouse liver.
    Wilson RB; Chen YJ; Zhang R; Maini S; Andrews TS; Wang R; Borradaile NM
    Am J Physiol Gastrointest Liver Physiol; 2024 Oct; 327(4):G608-G622. PubMed ID: 39136056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular pathogenesis of metabolic dysfunction-associated steatotic liver disease, steatohepatitis, hepatic fibrosis and liver cirrhosis.
    Saito T; Tsuchishima M; Tsutsumi M; George J
    J Cell Mol Med; 2024 Jun; 28(12):e18491. PubMed ID: 38894579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Normal caloric intake with high-fat diet induces metabolic dysfunction-associated steatotic liver disease and dyslipidemia without obesity in rats.
    Szudzik M; Hutsch T; Chabowski D; Zajdel M; Ufnal M
    Sci Rep; 2024 Oct; 14(1):22796. PubMed ID: 39354056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic miR-149-5p upregulation fosters steatosis, inflammation and fibrosis development in mice and in human liver organoids.
    Correia de Sousa M; Delangre E; Berthou F; El Harane S; Maeder C; Fournier M; Krause KH; Gjorgjieva M; Foti M
    JHEP Rep; 2024 Sep; 6(9):101126. PubMed ID: 39263327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Choline-deficient, high-fat diet-induced MASH in Göttingen Minipigs: characterization and effects of a chow reversal period.
    Hvid H; Hjuler ST; Bedossa P; Tiniakos DG; Kamzolas I; Harder LM; Xue Y; Perfield JW; Kirk RK; Latta M; Mikkelsen LF; Pedersen HD;
    Am J Physiol Gastrointest Liver Physiol; 2024 Oct; 327(4):G571-G585. PubMed ID: 39041677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of sleeve gastrectomy and dietary change on metabolic and hepatic function in an obesity rat model - Experimental research.
    Dohmen J; Praktiknjo M; Rudeloff A; Uschner FE; Klein S; Plamper A; Matthaei H; Rheinwalt KP; Wehner S; Kalff JC; Trebicka J; Lingohr P
    Int J Surg; 2020 Mar; 75():139-147. PubMed ID: 32014594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myeloid Trem2 ameliorates the progression of metabolic dysfunction-associated steatotic liver disease by regulating macrophage pyroptosis and inflammation resolution.
    Yu W; Zhang Y; Sun L; Huang W; Li X; Xia N; Chen X; Wikana LP; Xiao Y; Chen M; Han S; Wang Z; Pu L
    Metabolism; 2024 Jun; 155():155911. PubMed ID: 38609037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring the Regulatory Effect of LPJZ-658 on Copper Deficiency Combined with Sugar-Induced MASLD in Middle-Aged Mice Based on Multi-Omics Analysis.
    Li C; Liu Z; Wei W; Chen C; Zhang L; Wang Y; Zhou B; Liu L; Li X; Zhao C
    Nutrients; 2024 Jun; 16(13):. PubMed ID: 38999758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocyte-specific Epidermal Growth Factor Receptor Deletion Promotes Fibrosis but has no Effect on Steatosis in Fast-food Diet Model of Metabolic Dysfunction-associated Steatotic Liver Disease.
    Bano S; Copeland MA; Stoops JW; Orr A; Jain S; Paranjpe S; Mooli RGR; Ramakrishnan SK; Locker J; Mars WM; Michalopoulos GK; Bhushan B
    Cell Mol Gastroenterol Hepatol; 2024; 18(4):101380. PubMed ID: 39038606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic angiotensin-converting enzyme 2 expression in metabolic dysfunction-associated steatotic liver disease and in patients with fatal COVID-19.
    Jacobs AK; Morley SD; Samuel K; Morgan K; Boswell L; Kendall TJ; Dorward DA; Fallowfield JA; Hayes PC; Plevris JN
    World J Gastroenterol; 2024 Aug; 30(31):3705-3716. PubMed ID: 39192998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of ATGL alleviates MASH via impaired PPARα signalling that favours hydrophilic bile acid composition in mice.
    Dixon ED; Claudel T; Nardo AD; Riva A; Fuchs CD; Mlitz V; Busslinger G; Scharnagl H; Stojakovic T; Senéca J; Hinteregger H; Grabner GF; Kratky D; Verkade H; Zimmermann R; Haemmerle G; Trauner M
    J Hepatol; 2024 Sep; ():. PubMed ID: 39357546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.